novartis glp-1 receptor agonist weight management diabetes treatments APhA 2025: Agonists vs SGLT2 Inhibitors Show Varied Benefit for Cardiovascular Outcomes in Patients With Optimizing GLP-1 therapies for obesity

NMUAMT201807), Major Medical and Health Science and Technology Program of National Health and Health Commission-Zhejiang Province (No

Meanwhile, the analytical results from the two methods were mutually validated to ensure the robustness of the research findings

Low levels of vitamin B12 are one contributing factor to a slow metabolism, along with low thyroid hormone and low mitochondrial energy production

As we age, our bodies can become less efficient at absorbing vitamin B12 from food, increasing the risk of deficiency

Did you know that an estimated 40% of the population is deficient in vitamin B12

Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer